Congenital Bone Marrow Failure Syndromes are inherited conditions where the bone marrow doesn't produce enough blood cells. This can happen because of genetic changes affecting the stem cells that make blood. It can lead to problems with red blood cells, white blood cells, and platelets.
Every report comes from a Lived member, sent anonymously.
Have you had Stem Cell Transplant for Congenital Bone Marrow Failure Syndromes?
Congenital bone marrow failure syndromes, also called inherited bone marrow failure syndromes, are a group of rare genetic conditions in which the bone marrow cannot make enough blood cells. The bone marrow normally produces red blood cells, which carry oxygen; white blood cells, which fight infection; and platelets, which help blood clot. Depending on the syndrome, one of these cell types may fall short, or all three may. The shortages explain most of the early symptoms: tiredness and paleness from anemia, repeated or serious infections from low white cells, and easy bruising or bleeding from low platelets. Many of these syndromes also affect other parts of the body, and most carry a higher than usual risk of certain cancers, particularly cancers of the blood. They usually come to attention in childhood, but milder forms are sometimes recognized only in adulthood. This is an umbrella term rather than a single disease. The better known syndromes include Fanconi anemia, dyskeratosis congenita (now often grouped with related telomere biology disorders), Diamond-Blackfan anemia, Shwachman-Diamond syndrome and severe congenital neutropenia. They differ in which blood cells are affected, what else in the body is involved and how they are treated, so knowing the specific syndrome matters a great deal.
Each of these syndromes is caused by a change (variant) in a single gene, and more than 100 such genes are now known. The genes involved do very different jobs, such as repairing damaged DNA in Fanconi anemia, protecting the protective caps at the ends of chromosomes (telomeres) in dyskeratosis congenita, or building the cell's protein-making machinery in Diamond-Blackfan anemia. Blood-forming stem cells divide constantly, which makes them especially vulnerable when these processes fail. The gene change is present from conception, but it is not always passed down in an obvious way. Some syndromes appear only when a child inherits a nonworking copy of the gene from each parent, who are usually healthy carriers. Others need only one copy and can affect a parent and child, sometimes with very different severity, and some are linked to the X chromosome and mainly affect boys. In other cases the variant arises new in the child. Nothing a parent did during pregnancy causes these conditions. These syndromes are rare. One estimate puts all of them together at roughly 65 per million births, though many cases are thought to go unrecognized. Fanconi anemia and Diamond-Blackfan anemia are among the more common types.
The first clue is usually a blood count that is low in one or more cell types, sometimes alongside physical differences such as short stature, thumb or forearm differences, unusual skin coloring, or nail and mouth changes. A hematologist (a blood specialist) works out whether the low counts come from an inherited syndrome or from an acquired problem such as immune-related aplastic anemia, because the treatment, transplant planning and long-term monitoring are different. The workup usually includes a bone marrow test, in which a small sample is taken from the hip bone to see how many blood-forming cells are present and whether any look abnormal. Specialized blood tests point toward particular syndromes. A chromosome breakage test, which checks whether a person's chromosomes break unusually easily when their cells are exposed to certain DNA-damaging chemicals, is the classic screening test for Fanconi anemia, and children with aplastic anemia (marrow that has stopped making enough of all blood cell types) or myelodysplastic syndrome (a precancerous marrow disorder) are generally tested for it. Measuring telomere length helps screen for dyskeratosis congenita and related disorders, and signs of poor pancreatic function point toward Shwachman-Diamond syndrome. Genetic testing, often a panel that checks many bone marrow failure genes at once, can confirm the specific syndrome. It does not always give a clear answer: a gene change may be found whose meaning is uncertain, and some people with a clear inherited pattern have no identified gene. Genetic counseling helps families understand results and whether brothers, sisters or other relatives should be tested.
Treatment depends on the specific syndrome, how low the blood counts are and the person's age and overall health. Supportive care is the foundation for most people: red blood cell and platelet transfusions when counts are too low, and prompt antibiotics for infections. Repeated red cell transfusions build up iron in the body, so people who need them regularly usually also take iron-lowering medicine (iron chelation) to protect the heart, liver and other organs. Several syndromes have targeted medical treatments. In Diamond-Blackfan anemia, steroid medicine (prednisone or prednisolone) restores red cell production in up to 80 percent of people at first, and the dose is kept as low as possible to limit side effects, including effects on a child's growth. In Fanconi anemia and dyskeratosis congenita, androgens, which are male hormone medicines such as danazol, raise blood counts in many people, sometimes for years. They can cause masculinizing effects, high blood pressure and liver problems, need regular monitoring, and do not lower the risk of leukemia. In severe congenital neutropenia, injections of G-CSF (granulocyte colony-stimulating factor, a growth factor such as filgrastim, sold as Neupogen) raise the infection-fighting neutrophil count in more than 90 percent of people. In Shwachman-Diamond syndrome, pancreatic enzyme capsules and vitamins help with digestion and growth. A stem cell transplant (bone marrow transplant), which replaces the person's blood-forming cells with a donor's, is currently the only treatment that can cure the bone marrow failure. It does not correct the other features of the syndrome, and it carries serious risks, including life-threatening complications, graft-versus-host disease (donor immune cells attacking the body) and later cancers, so the timing is decided case by case. People with these syndromes often need gentler, specially adjusted transplant regimens. If a brother, sister or other relative is considered as a donor, they need to be tested first to make sure they do not carry the same condition. Gene therapy has shown some early success in one type of Fanconi anemia but remains experimental.
These are lifelong conditions, and the course varies widely between syndromes and even within one family. Some people have only mildly low counts for years, while others need regular transfusions or a transplant in childhood. Blood counts can also worsen over time, and a person's needs may change as they grow. Ongoing care usually happens in a specialist center, often with a hematologist leading a team that may include genetics, gastroenterology, lung, skin, dental and endocrine specialists, depending on the syndrome. Regular blood counts, and periodic bone marrow tests, look for worsening marrow failure or early signs of myelodysplastic syndrome or acute myeloid leukemia. People with Fanconi anemia or dyskeratosis congenita also have a raised risk of other cancers, especially of the mouth, throat and genital area, so regular screening of these areas is part of routine care. Daily habits matter more than for most people. Some syndromes, such as dyskeratosis congenita, can also scar the lungs over time. Avoiding smoking, limiting alcohol and protecting the skin from the sun help lower cancer and lung risks. Because people with these syndromes can be more sensitive to many medicines, and people with Fanconi anemia are especially sensitive to chemotherapy and radiation, any new medicine or procedure should be checked with the specialist team. Families often benefit from genetic counseling, school or work support and connection with syndrome-specific patient organizations.
Ask for a blood count and a referral to a hematologist if a child or adult has unexplained low blood counts, frequent infections, persistent tiredness and paleness, or easy bruising, especially alongside physical differences such as thumb or forearm differences, short stature, nail changes or fatty stools with poor growth. Relatives of someone with a known syndrome should ask whether they should be tested. For someone already diagnosed, contact the care team promptly about new or unusual bleeding, such as nosebleeds that are hard to stop, bleeding gums or tiny red spots on the skin, or about growing tiredness and shortness of breath that may signal falling counts. A new lump, a mouth sore or white patch that does not heal, or a change in breathing should also be checked rather than left to the next routine visit. A fever or other sign of infection in someone whose white cell count is low is urgent. Contact the hematology team right away, day or night, and follow the fever plan they have given, which often means going straight to the hospital, because these infections can become serious within hours and need antibiotics quickly. Bleeding that will not stop with pressure, blood in vomit or stool, or a head injury or sudden severe headache while platelets are low needs emergency care right away.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Congenital Bone Marrow Failure Syndromes is like, what's helped you, or ask the community a question.